The rapid evolution of Artificial Intelligence is reshaping the landscape of gynecologic oncology, offering unprecedented opportunities for precision diagnostics, risk stratification, and personalized treatment planning.

This CME-accredited webinar brings together leading national and worldwide experts to explore the integration of AI and emerging technologies across ovarian, cervical, and endometrial cancers.

Through a series of state-of-the-art lectures and evidence-based insights, participants will gain a comprehensive overview of current innovations, from biomarker-driven pathology to AI-powered surgical decision-making.

The program concludes with a dedicated surgical high-level video session, showcasing advanced techniques and fostering practical learning to support excellence in patient care.

Alessandro Buda